PARK INNOVARE

Blog

Shaping the future of modern drug discovery

Video interview with Professor Dr. Gebhard Schertler Pharmaceutical and biotechnological industries often depend on the information acquired through...

More details More details

Women’s passion – the new frontier of innovation

Based on the “Appassionate” project – a book about women who transform their own passion into enterprises My work has always been to find stories...

More details

Emerging applications of modular nanomaterials

When, back in 1999, the journal Nature published a letter about a material with a surface area of 2900 square meters in a single gram, many people believed...

More details

Life Science basic research on the top level

The Paul Scherrer Institute (PSI) is Switzerland’s biggest research institute for natural and engineering sciences. It hosts most of the country’s...

More details

A perfect site for biotech and pharma companies!

Drug discovery has come a long way from crude extracts to pure chemicals, from guess work to a structural and targeted approach to finding new and better...

More details

Infrastructure and R&D solutions for biotech and pharmaceutical industries

The Swiss Light Source (SLS) at the Paul Scherrer Institute (PSI) and the free-electron laser (SwissFEL) provide beams of exceptional brightness and stability...

More details

Biotech and pharma at PARK INNOVAARE

PARK INNOVAARE provides the best possible operating conditions for biotech and pharmaceutical companies. This includes the availability of modern laboratories...

More details

Corporate Innovation Makeover: Excubation rules for the core business

This blog post is dedicated to the final three Excubation rules, and thus concludes our Corporate Innovation Makeover series. These three rules focus on...

More details

Corporate Innovation Makeover: Excubation rules 3 and 4

Building on the excubation conversation we started in this blog series, and having introduced first two rules of the approach, we dive here into the next...

More details

Unprecedented speed and success rate with delivering ligand-bound GPCR structures

Modern drug discovery greatly benefits from knowledge of how a drug interacts with its molecular drug target. Membrane protein drug targets represent a...

More details

How can KPI steer your innovation process?

PARK INNOVAARE works at the interface of technology-driven companies and public research, such as at the nearby Paul Scherrer Institute (PSI). In one of...

More details

Methodically secret: what should you consider with respect to your know-how and trade secrets?

It falls short of a full appreciation of innovation to consider only patentable inventions. Process innovation, for instance, is usually not patentable....

More details